PARK7/DJ-1 as a Therapeutic Target in Gut-Brain Axis Diseases.

Pap, Domonkos; Veres-Székely, Apor; Szebeni, Beáta; Vannay, Ádám

Pap, Domonkos; Veres-Székely, Apor; Szebeni, Beáta; Vannay, Ádám.

Afiliação

Pap D; 1st Department of Pediatrics, Semmelweis University, 1083 Budapest, Hungary.
Veres-Székely A; ELKH-SE Pediatrics and Nephrology Research Group, 1052 Budapest, Hungary.
Szebeni B; 1st Department of Pediatrics, Semmelweis University, 1083 Budapest, Hungary.
Vannay Á; ELKH-SE Pediatrics and Nephrology Research Group, 1052 Budapest, Hungary.

Int J Mol Sci ; 23(12)2022 Jun 14.

Article em En | MEDLINE | ID: mdl-35743072

Assuntos

Microbioma Gastrointestinal; Doenças Neurodegenerativas; Doença de Parkinson; Eixo Encéfalo-Intestino; Humanos; Doenças Neurodegenerativas/metabolismo; Doença de Parkinson/metabolismo; Proteína Desglicase DJ-1/metabolismo

Palavras-chave

Alzheimer's disease; Crohn's disease; PARK7/DJ-1; Parkinson's disease; blood-brain barrier; gut-brain axis; inflammatory bowel diseases; neurodegenerative disorders; oxidative stress; ulcerative colitis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Doenças Neurodegenerativas / Microbioma Gastrointestinal Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google